This Week in Cardiology Feb 14 2025 This Week in Cardiology
Feb 14, 2025
Explore the intriguing issue of silent cerebral embolism following left atrial appendage closure, highlighting its unexpected connection to cognitive decline. Discover how AI is revolutionizing ECG monitoring, improving the detection of critical arrhythmias. Dive into the debate over anticoagulation methods in patients with atrial fibrillation and chronic coronary disease, emphasizing the potential advantages of oral anticoagulation monotherapy. This fascinating discussion is packed with insights for healthcare professionals.
AI Snips
Chapters
Transcript
Episode notes
Silent Cerebral Embolism Post LAAC
- A study found 39% of patients had silent cerebral embolism post left atrial appendage closure (LAAC).
- 15% developed new subclinical embolisms during follow-up, with lower neurocognitive test scores.
AI vs. Humans in ECG Analysis
- An AI model called Deep Rhythm outperformed ECG technicians in identifying critical arrhythmias.
- The AI had a 98.6% sensitivity vs 80.3% for technicians, reducing misdiagnosis risk 14-fold.
Anticoagulation in AFib and CAD
- Oral anticoagulation monotherapy is preferable to combination therapy for patients with AFib and stable CAD.
- Monotherapy reduces major bleeding risk without impacting efficacy, according to a meta-analysis.